Chemoinformaics analysis of 3-mercapto-2-methypentan-1-ol.
| Molecular Weight | 134.244 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.132 | nRig | 0 |
| Exact Molecular Weight | 134.077 | nRing | 0 |
| Solubility: LogS | -1.461 | nHRing | 0 |
| Solubility: LogP | 1.673 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 23.0571 |
| nHD | 2 | BPOL | 16.5049 |
| QED | 0.558 |
| Synth | 4.034 |
| Natural Product Likeliness | 1.186 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.014 |
| CACO-2 | -4.602 |
| MDCK | 0.0000471 |
| BBB | 0.471 |
| PPB | 0.807729 |
| VDSS | 1.018 |
| FU | 0.206214 |
| CYP1A2-inh | 0.163 |
| CYP1A2-sub | 0.469 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.795 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.376 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.406 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.3 |
| CL | 11.359 |
| T12 | 0.805 |
| hERG | 0.011 |
| Ames | 0.128 |
| ROA | 0.116 |
| SkinSen | 0.137 |
| Carcinogencity | 0.559 |
| EI | 0.59 |
| Respiratory | 0.661 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.951689 |